Skip to main content
. 2018 Apr 19;1(1):68–73. doi: 10.1002/ame2.12004

Table 4.

Fatty degeneration of liver and kidney

Group Blank M E1L E1H E2L E2H
No. 1 2 3 4 5 6 7 8 9 10 11 12
Fatty degeneration in liver N N +++ +++ N N + N N + N+ N
Fatty degeneration in kidney N N +++ ++ + N + + N + N N

N, no abnormity; +, slight lesioning; ++, no remarkable lesioning; +++, remarkable lesioning. M, T2DM model; E1H and E1L, flavonoid high and low doses, respectively; E2H and E2L, stilbene glycoside high and low doses, respectively.